About the Bionics Institute


Bionics Institute Research Online >
Other staff research publications >
Other research publications >

Title: Differential effects of vagus nerve stimulation strategies on glycemia and pancreatic secretions
Authors: Payne, Sophie
Ward, Glenn
MacIsaac, Richard
Hyakumura, Tomoko
Fallon, James
Villalobos, Joel
Keywords: Bioelectronic medicine
Medical devices
Peripheral nerve stimulation
Type 2 diabetes mellitus
Issue Date: Jun-2020
Publisher: Wiley Periodicals LLC
Citation: Payne, S. C., G. Ward, R. J. MacIsaac, T. Hyakumura, J. B. Fallon, and J. Villalobos. 2020. Differential effects of vagus nerve stimulation strategies on glycemia and pancreatic secretions. Physiological reports. 8(11): e14479.
Abstract: Despite advancements in pharmacotherapies, glycemia is poorly controlled in type 2 diabetic patients. As the vagus nerve regulates energy metabolism, here we evaluated the effect various electrical vagus nerve stimulation strategies have on glycemia and glucose-regulating hormones, as a first step to developing a novel therapy of type 2 diabetes. Sprague-Dawley rats were anesthetized, the abdominal (anterior) vagus nerve implanted, and various stimulation strategies applied to the nerve: (a) 15 Hz; (b) 4 kHz, or 40 kHz and; (c) a combination of 15 Hz and 40 kHz to directionally activate afferent or efferent vagal fibers. Following a glucose bolus (500 mg/kg, I.V.), stimulation strategies were applied (60 min) and serial blood samples taken. No stimulation was used as a crossover control sequence. Applying 15 Hz stimulation significantly increased glucose (+2.9 ± 0.2 mM·hr, p = .015) and glucagon (+17.1 ± 8.0 pg·hr/ml, p = .022), compared to no stimulation. Application of 4 kHz stimulation also significantly increased glucose levels (+1.5 ± 0.5 mM·hr, p = .049), while 40 kHz frequency stimulation resulted in no changes to glucose levels but did significantly lower glucagon (-12.3 ± 1.1 pg·hr/ml, p = .0009). Directional afferent stimulation increased glucose (+2.4 ± 1.5 mM·hr) and glucagon levels (+39.5 ± 15.0 pg·hr/ml). Despite hyperglycemia resulting when VNS, aVNS, and 4 kHz stimulation strategies were applied, the changes in insulin levels were not significant (p ≥ .05). In summary, vagus nerve stimulation modulates glycemia by effecting glucagon and insulin secretions, and high-frequency 40 kHz stimulation may have potential application for the treatment of type 2 diabetes.
URI: http://repository.bionicsinstitute.org:8080/handle/123456789/399
ISSN: 2051-817x
Appears in Collections:Other research publications

Files in This Item:

File Description SizeFormat
2020_Payne_Differentialeffects.pdf1.09 MBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


DSpace Software Copyright © 2002-2010  Duraspace -